Jump Financial, LLC Corbus Pharmaceuticals Holdings, Inc. Transaction History

Jump Financial, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$0.21 - $0.53 $3,115 - $7,863	-14,836 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$0.32 - $0.67 $2,702 - $5,657	-8,444 Reduced 36.27%	14,836 $8,000
Q4 2021 Feb 10, 2022	BUY	$0.6 - $1.11 $1,455 - $2,691	2,425 Added 11.63%	23,280 $14,000
Q3 2021 Nov 12, 2021	SELL	$1.01 - $1.82 $2,637 - $4,752	-2,611 Reduced 11.13%	20,855 $21,000
Q2 2021 Aug 13, 2021	BUY	$1.39 - $2.21 $32,617 - $51,859	23,466 New	23,466 $43,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.08B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.